Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov;34(6):e15113.
doi: 10.1111/dth.15113. Epub 2021 Sep 7.

COVID-19 and exacerbation of dermatological diseases: A review of the available literature

Khashayar Aram  1   2 , Anant Patil  3 , Mohamad Goldust  4 , Fateme Rajabi  2   5
Affiliations

COVID-19 and exacerbation of dermatological diseases: A review of the available literature

Khashayar Aram et al. Dermatol Ther. 2021 Nov.

Abstract

Since the emergence of the new coronavirus disease 19 (COVID-19) pandemic, there has been a concern for the patients with chronic autoimmune diseases including dermatological conditions over the potential exacerbation of these underlying conditions after infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV2). We performed a systematic review to evaluate presentations, postinfection change in the manifestation, diagnosis, and management of flare-ups of underlying dermatologic disease in patients with COVID-19. A total of 17 articles were recovered reporting on flare-ups of dermatological disease including pemphigus vulgaris, psoriasis, subacute cutaneous lupus erythematosus, acrodermatitis continua of Hallopeau, systemic sclerosis sine scleroderma, and Sézary syndrome (SS). Out of these, psoriasis and alopecia areata were the most common conditions. However, most cases of psoriasis could have been attributed to either antimalarial agents that were initially used for the treatment of COVID-19 or discontinuation of treatment following SARS-CoV2 infection.

Keywords: COVID-19; SARS-Cov2; dermatology; exacerbation; flare-up; pemphigus; psoriasis; worsening.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare. The article has never been presented anywhere else.

Figures

FIGURE 1
FIGURE 1
Flow chart of literature search
See this image and copyright information in PMC

References

    1. Shakoei S, Ghanadan A, Hamzelou S. Pustular psoriasis exacerbated by COVID‐19 in a patient with the history of psoriasis. Dermatol Ther. 2020;33(6):e14462. doi: 10.1111/dth.14462 - DOI - PMC - PubMed
    1. Shahidi Dadras M, Diab R, Ahadi M, Abdollahimajd F. Generalized pustular psoriasis following COVID‐19. Dermatol Ther. 2021;34(1): e14595. doi: 10.1111/dth.14595 - DOI - PMC - PubMed
    1. Sigha OB, Kouotou EA. COVID‐19 infection revealed by a flare‐up of psoriasis in an elderly Cameroonian: about a case; 2021.
    1. Gananandan K, Sacks B, Ewing I. Guttate psoriasis secondary to COVID‐19. BMJ Case Rep. 2020;13(8):e237367. doi: 10.1136/bcr-2020-237367 - DOI - PMC - PubMed
    1. Carugno A, Gambini DM, Raponi F, et al. Coronavirus disease 2019 (COVID‐19) rash in a psoriatic patient treated with Secukinumab: is there a role for interleukin 17? Dermatol Ther. 2020;33(6):e14011. doi: 10.1111/dth.14011 - DOI - PMC - PubMed

Publication types